• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Skin cancer in kidney transplant recipients affected with autosomal dominant polycystic kidney disease.

作者信息

Jankowska Magdalena, Dębska-Ślizień Alicja, Imko-Walczuk Beata, Piesiaków Maria-Luiza, Lizakowski Sławomir, Czarnacka Kamila, Rutkowski Bolesław

机构信息

Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland.

Dermatology and Venerology, Independent Public Healthcare, Copernicus Hospital, Gdańsk, Poland.

出版信息

Clin Transplant. 2016 Apr;30(4):339-43. doi: 10.1111/ctr.12707. Epub 2016 Feb 24.

DOI:10.1111/ctr.12707
PMID:26916353
Abstract
摘要

相似文献

1
Skin cancer in kidney transplant recipients affected with autosomal dominant polycystic kidney disease.患有常染色体显性多囊肾病的肾移植受者的皮肤癌
Clin Transplant. 2016 Apr;30(4):339-43. doi: 10.1111/ctr.12707. Epub 2016 Feb 24.
2
Autosomal dominant polycystic kidney disease: risk factor for nonmelanoma skin cancer following kidney transplantation.常染色体显性多囊肾病：肾移植后非黑色素瘤皮肤癌的危险因素。
Transpl Int. 2010 Sep;23(9):878-86. doi: 10.1111/j.1432-2277.2010.01070.x. Epub 2010 Mar 5.
3
Belatacept reduces skin cancer risk in kidney transplant recipients.贝拉西普可降低肾移植受者患皮肤癌的风险。
J Am Acad Dermatol. 2020 Apr;82(4):996-998. doi: 10.1016/j.jaad.2019.09.070. Epub 2019 Oct 4.
4
Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.与背景人群和肾移植受者相比，造血干细胞移植受者的皮肤癌风险：一项基于人群的队列研究。
JAMA Dermatol. 2016 Feb;152(2):177-83. doi: 10.1001/jamadermatol.2015.3902.
5
Posttransplant Outcomes of Patients With Autosomal Dominant Polycystic Kidney Disease Versus Other Recipients: A 10-Year Report From South of Iran.常染色体显性多囊肾病患者与其他受者的移植后结局：来自伊朗南部的10年报告
Exp Clin Transplant. 2018 Dec;16(6):676-681. doi: 10.6002/ect.2016.0163. Epub 2016 Oct 14.
6
Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort.多基因风险评分作为欧洲血统肾移植队列中非黑色素瘤皮肤癌风险的决定因素。
Am J Transplant. 2019 Mar;19(3):801-810. doi: 10.1111/ajt.15057. Epub 2018 Sep 5.
7
Factors associated with skin cancer in lung transplant recipients: A single-center experience.肺移植受者皮肤癌相关因素：单中心经验。
Clin Transplant. 2019 Dec;33(12):e13718. doi: 10.1111/ctr.13718. Epub 2019 Nov 7.
8
Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome.肾移植受者急性移植物肾盂肾炎：发病率、危险因素和长期预后。
Nephrol Dial Transplant. 2011 Mar;26(3):1065-73. doi: 10.1093/ndt/gfq531. Epub 2010 Aug 30.
9
Outcome of Kidney Transplant in Patients with Polycystic Kidney Disease: A Single-Center Study in Tunisia.多囊肾病患者肾移植的结局：突尼斯的一项单中心研究
Exp Clin Transplant. 2017 Feb;15(Suppl 1):196-199. doi: 10.6002/ect.mesot2016.P78.
10
Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.葡萄牙肾移植受者的非黑色素瘤皮肤癌——发病率及危险因素
An Bras Dermatol. 2016 Jul-Aug;91(4):455-62. doi: 10.1590/abd1806-4841.20164891.

引用本文的文献

1
Non-melanoma skin cancer outcomes in kidney transplant recipients converted from calcineurin inhibitors to mTOR inhibitors: a systematic review.肾移植受者从钙调神经磷酸酶抑制剂转换为mTOR抑制剂后的非黑色素瘤皮肤癌结局：一项系统评价
Postepy Dermatol Alergol. 2023 Apr;40(2):187-193. doi: 10.5114/ada.2023.127637. Epub 2023 Jun 1.
2
Novel non-cystic features of polycystic kidney disease: having new eyes or seeking new landscapes.多囊肾病的新型非囊性特征：拥有新视角或探寻新景象。
Clin Kidney J. 2020 Sep 7;14(3):746-755. doi: 10.1093/ckj/sfaa138. eCollection 2021 Mar.
3
ADPKD: clinical issues before and after renal transplantation.
常染色体显性多囊肾病：肾移植前后的临床问题
J Nephrol. 2016 Dec;29(6):755-763. doi: 10.1007/s40620-016-0349-7. Epub 2016 Oct 20.